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Abstract
This paper seeks to understand whether a catastrophic and urgent event, such as the first
months of the COVID-19 pandemic, accelerates or reverses trends in international collabo-
ration, especially in and between China and the United States. A review of research articles
produced in the first months of the COVID-19 pandemic shows that COVID-19 research had
smaller teams and involved fewer nations than pre-COVID-19 coronavirus research. The
United States and China were, and continue to be in the pandemic era, at the center of the
global network in coronavirus related research, while developing countries are relatively
absent from early research activities in the COVID-19 period. Not only are China and the
United States at the center of the global network of coronavirus research, but they
strengthen their bilateral research relationship during COVID-19, producing more than 4.9%
of all global articles together, in contrast to 3.6% before the pandemic. In addition, in the
COVID-19 period, joined by the United Kingdom, China and the United States continued
their roles as the largest contributors to, and home to the main funders of, coronavirus
related research. These findings suggest that the global COVID-19 pandemic shifted the
geographic loci of coronavirus research, as well as the structure of scientific teams, narrow-
ing team membership and favoring elite structures. These findings raise further questions
over the decisions that scientists face in the formation of teams to maximize a speed, skill
trade-off. Policy implications are discussed.
Introduction
The global pandemic caused by the widespread coronavirus, COVID-19, stimulated extraordi-
nary amounts of scientific inquiry around the world. The virus first appeared in the scholarly
literature on the 24 January 2020 [1], and subsequently, virologists and immunologists worked
to isolate and identify the virus, determine its etiology, define the vulnerabilities that may
allow treatment, and conduct research on drug and vaccine development. While international
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collaboration and cooperation are critical actions to address global pandemics, the need for
rapid and urgent solutions could render cross-border teamwork more difficult, due to the
transaction costs of communication and rising political tensions. This article tracks patterns of
international collaboration in coronavirus-related research before and in the period immedi-
ately after the start of the COVID-19 pandemic in order to understand how scientists lever-
aged complementary expertise within their own nation’s borders and beyond.
International collaboration in scientific research has grown at a spectacular level since the
1980s, when geopolitical shifts opened up opportunities for formerly restricted researchers to
create relationships outside their nation or region [2,3]. The breakup of the Soviet Union, the
reunification of Germany, and China’s decision to create the “four modernizations” to include
science and technology in a process of opening up (改革开放), all served to restructure sci-
ence. In particular, collaborations between China and the United States have grown rapidly,
and the rate of collaboration between these two countries are now more numerous than any
two countries in the world [2].
While international collaborations can help scientists in one country to access complemen-
tary expertise outside their country’s borders, there are search and coordination costs associ-
ated with such collaborations [4–6]. International collaborative research activities operate as a
network [7] which takes time to traverse. No international organization oversees or directs
these works: researchers find each other based on shared interests and the needs of frontier sci-
ence. This is particularly true for sciences of immunology and virology, where no central labo-
ratory or common data set is on hand as an organizing force [7].
COVID-19, the coronavirus that emerged in late 2019 and grew to a global pandemic in
early 2020, presented this trade-off between novelty and efficiency to the international com-
munity of scholars. The importance of global collaboration and coordination to resolve this
enormous challenge is summarized by the director of the United States National Institutes of
Health (NIH), stating:
“We need to bring the full power of the biomedical research enterprise to bear on this crisis.
Now is the time to come together with unassailable objectivity to swiftly advance the develop-
ment of the most promising vaccine and therapeutic candidates that can help end the
COVID-19 global pandemic.”
NIH Director Dr. Francis S. Collins. April 2020
But at the same time, the urgent need for solutions to combat the pandemic increases the
cost of search and coordination needed in internationally collaborative work.
In a time of urgency, we expect that scientists reduce their collaborations, or seek to work with
known colleagues to reduce the transaction costs of communication. We hypothesize that the
pressures presented by the coronavirus crisis would lead scientists to collaborate internationally at
a lower rate than before the pandemic. We expect search to be reduced, and pre-existing relation-
ships to be strengthened, to the exclusion of scientists from less developed institutions, regions, or
nations. In addition to a test of these hypothesis, in this study we explore whether these shifts dur-
ing the early months of the pandemic altered the geographic locus of coronavirus research, and
whether there are implications for the quality, and type, of work produced.
Methods
In order to achieve the goals of the study, the project team constructed two brand new datasets:
one to capture measures on collaborations in coronavirus research prior to the COVID-19 cri-
sis, and one for the COVID-19 crisis period. The pre-COVID-19 period extends for 24 months
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prior to December 2019. The COVID-19 period extends from January 1, 2020 to April 23,
2020. Measures of collaboration (and others) are generated using scientific articles.
A complete dataset of scientific articles on coronavirus-related research between January 1,
2018 and April 23, 2020 are extracted from the Clarivate Web of Science (WoS), Elsevier Sco-
pus, and PMC-sourced materials drawn from CORD-19 (COVID-19 Open Research Dataset).
Any overlap between articles found across the different source materials were removed. To
complement the data on published articles, we also drew preprint articles between January 1
and April 23 2020 from bioRxiv.org, medRxiv.org, and arXiv.org, extracted through the
Dimensions database. The following consistent set of keywords was used in searches in the
Title/Abstract/Keywords of each article in the respective databases:
• "COVID-19" OR "2019-nCoV" OR "coronavirus" OR "Corona virus" OR "SARS-CoV" OR
"MERS-CoV" OR "Severe Acute Respiratory Syndrome" OR "Middle East Respiratory
Syndrome"
Table 1 shows the composition of the datasets in the pre-COVID-19 and during COVID-
19. Using the search procedure outlined, the data comprise a total of 10,432 coronavirus-
related articles and preprints with author identifiable information across the two periods for
analysis. Within these data, 5,934 articles are published in peer-reviewed journals; the remain-
der of the works comprise reviews, conference proceedings, and preprints (considered ‘infor-
mal’ hereafter).
Pre-COVID-19 analysis is limited to published records because the historical data are stan-
dardized in indexed databases. This allows others to recreate the dataset and test the validity of
this analysis. Moreover, enough time had passed to allow most works from pre-COVID-19 to
be peer reviewed and published in recognized scholarly venues (an anonymized dataset for
this project are also made available on figshare). The COVID-19 period includes both peer-
reviewed and preprint materials. We include preprint materials because the time pressures
imposed by the pandemic crisis propelled ready and open sharing of even initial results:
researchers put materials into circulation to provide insights for others without waiting for
peer review. This process means that, at the time of this writing, many coronavirus-related
articles have not had time to be peer reviewed and published in established venues. By neces-
sity, this means that the COVID-19 dataset includes materials that are questionable in their sci-
entific rigor and that may be methodologically unsound. Future work will return to the
materials to re-evaluate the published record for those materials that have failed to make it
through the peer-review process.
The data are examined for several features: 1) publication patterns and numbers; 2) public
funding patterns to compare pre- and COVID-19, as available; 3) the structure of scientific
teams; 4) quality measures of formal publications; 5) collaborative patterns at the international
level; and 6) networked collaborations including measures of egonets at the international level.
Table 1. Data source and publication data.
Source Pre-COVID-19 (January 1st 2018 –December 31st 2019) COVID-19
Scopus 1,917 1,714
Web of Science 1,448 822
PMC 4,198 4,334
Preprints (BioRxiv/MedRxiv) 2,147
Combined (duplicates dropped) 6,337 5,083
Combined, with author affiliation data 6,105 4,327
https://doi.org/10.1371/journal.pone.0236307.t001
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For each article in the datasets, variables of interest are created based on author institutional
affiliation, publication journal impact measures, and funding support.
To test any changes in publication patterns and team structure between articles in the pre-
and COVID-19 period, we run a series of tests to ascertain any statistically significant changes.
Specifically, we use a combination of one-tailed T-tests and ordinary least squares to ascertain
any average differences in article features between the two groups. The one-tailed T-tests com-
pare the mean of variables of the two groups and using the standard deviation of the two sam-
ples allows us to assess whether the variables in question come from the same distribution, or
different. Statistical significance is assessed at the 0.1, 0.05, and 0.01 level.
To test any dynamic change in network structure of researchers between pre-COVID-19
and during COVID-19, we construct global collaboration networks based on international
coauthorships. Collaboration links are first established by addresses in articles, based on a full
counting method. Then, co-occurrence matrices are created to show which countries are coau-
thoring articles together. The coauthorship links are aggregated by country pairs and imported
into software VOSviewer [8] and Gephi [9] for network analysis that allows for a statistical
review of the whole sample of collaborating countries and allows visualization of the connec-
tions. To assess any changes in network positions of nations, we calculate several network met-
rics for selected nations in both periods, namely: a. Degree, the number of connecting nodes
or collaboration partners of a focal country; b. Weighted Degree, a measure of the number of
collaboration links a nation has [10]; c. Normalized Betweenness Centrality, a measure of how
often a node appears on the shortest path between other nodes in the network [11] and Eigen-
vector Centrality measures the influence of hubs in a network [12].
Finally, in order to visualize the landscape of the COVID-19 research and compare any
change in research interest between the pre- and COVID-19 period from the perspective of
topic analysis, we conduct a keyword-based bibliometric analysis to generate a co-term net-
work for the two periods respectively. With the aid of VantagePoint—a software platform for
bibliometrics-based text analytics owned by Search Technology Inc, we collect COVID-
19-related core terms by exploiting a term clumping process [13] and create co-term networks,
in which each node represents a core term and each edge reflects the co-occurrent frequency
of its connected terms. VOSviewer [8] is used for visualizing the networks in the form of sci-
ence maps.
Results
The aforementioned propositions are tested using statistical and network tests designed to
ascertain differences in publication patterns, the structures of teams and international rates of
collaboration in coronavirus-related research before and during the COVID-19 global
pandemic.
National contributions to coronavirus articles
Following the COVID-19 outbreak, as expected given the geographic spread of the pandemic
[14], coronavirus-related articles are more likely to be authored by scientists based in China
and Italy than before the outbreak. As the two nations that experienced the earliest outbreaks
of the virus, this suggests that a need for solutions and access to patient populations can stimu-
late research productivity in a topic. In contrast, fewer articles emanate from other OECD or
developing countries in the early COVID-19 period as compared to before the pandemic.
Table 2 compares the geographic sources of coronavirus research in the pre- and COVID-19
research datasets. It is clear that China takes the lead on research publications during the
COVID-19 period, with the percentage of Chinese articles growing to 39% from 22% prior to
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the outbreak, while the United States’ output drops as a share of total output during the
COVID-19 period.
Table 3 provides a comparison of the quantity of articles produced by China and the United
States in the pre- and COVID-19 periods available at the time of writing. The number of arti-
cles produced by Chinese authors in the first three months of the COVID-19 period—more
than 1,600 articles—surpasses the number of coronavirus articles produced by Chinese-based
authors in the entire previous 24 months. As a preliminary exploration into the extent of Chi-
na’s involvement in international collaborative research Table 3 also reveals that by April 2020,
Chinese authors together with international collaborators produced over 12% of articles in the
topic of ‘coronavirus’–again, more than the volume that they produced across 2018 and 2019
together. In contrast, United States-based scholars produced just under half of the volume
combined of international collaborative research that they produced in 2018 and 2019. This
finding is explored further in subsequent sections of the paper.
We turn our analysis from the national to the institutional level in Fig 1, and assess which
institutions are the top producers of coronavirus research in the pre- and COVID-19 period.
Consistent with Tables 2 and 3, we find that Chinese institutions lead the world in terms of
volume of coronavirus articles (including both published articles and preprints) in both the
pre- and COVID-19 periods. Moreover, during the COVID-19 period, eight out of top ten of
the most prolific institutions are located in China. Wuhan University (which includes Renmin
Hospital and Zhongnan Hospital) and Huazhong University of Science and Technology
(which includes Tongji Hospital, Tongji Medical College, and Wuhan Union Hospital),
located in Wuhan, China are the most prolific institutions during COVID-19, followed by the
University of Hong Kong, and Fudan University. However, the Chinese Centers for Disease
Control (Chinese CDC), which leads coronavirus research output in the pre-COVID-19 era,
drops down the list in the COVID-19 period. In contrast to the rise of some Chinese
Table 2. Author location in COVID-19 vs pre-COVID-19 research.
Pre-COVID-19 (N = 6,105) COVID-19 (N = 4,327) COVID-19 (minus preprints)
(N = 2,472)
Mean Median Std Dev Mean Median Std Dev p-value Mean Median Std Dev p-value
Authors China 0.22 0 0.41 0.39��� 0 0.49 .000 0.42��� 0 0.49 .000
Authors OECD 0.67��� 1 0.47 0.58 1 0.50 .000 0.54 0 0.50 .000
Authors United States 0.35��� 0 0.48 0.28 0 0.45 .000 0.25 0 0.43 .000
Authors United Kingdom 0.090 0 0.29 0.098 0 0.30 .091 0.096 0 0.29 .207
Authors Italy 0.035 0 0.19 0.051��� 0 0.22 .000 0.059��� 0 0.24 .000
Authors Asia, not China 0.27��� 0 0.44 0.17 0 0.37 .000 0.19 0 0.39 .000
Authors, not China NOR Europe NOR OECD 0.15��� 0 0.35 0.11 0 0.32 .000 0.12 0 0.32 .000
�, ��, ��� denote statistical significance at p-values of 0.1, 0.05 and 0.01 in a difference of means test comparing pre- and COVID-19 outcomes. Comparisons are between
pre-COVID-19 outcomes and COVID-19 era outcomes.
https://doi.org/10.1371/journal.pone.0236307.t002
Table 3. Number of publications in COVID-19 vs pre-COVID-19 research, by author country.
Pre-COVID-19 (% of total global articles)
January 2018-December 31 2019
COVID-19 (% of total global articles)
January 1 2020 –April 23 2020
COVID-19 (minus preprints) (% of total
global articles) January 1 2020 –April 8 2020
Overall International Teamed Articles Overall International Teamed Articles Overall International Teamed Articles
Total global articles 6,105 4,327 2,472
China 1,341 (22%) 469 (7%) 1,671 (39%) 507 (12%) 1,069 (42%) 332 (13%)
United States 2,122 (35%) 1,129 (18%) 1,202 (28%) 533 (12%) 605 (24%) 326 (13%)
https://doi.org/10.1371/journal.pone.0236307.t003
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institutions in the COVID-19 period, the United States National Institutes of Health drops out
of the top ten most prolific institutions during COVID-19 at the time of writing of this study.
When we exclude preprints from the analysis, we observe that Fudan University drops a lot in
ranking and the University of Oxford and Harvard University drop out of the top ten most
prolific institutions during the COVID-19 period, leaving the top ten institutions to exclusively
consist of Chinese institutions.
Reported funding for coronavirus research
Next, we examine the most commonly acknowledged funding agencies in coronavirus
research before and during the COVID-19 period (Table 4). Self-reported funding data is
aggregated where possible across published articles found in the Web of Science (WoS) and
Elsevier Scopus database. We find that during the COVID-19 period, Chinese agencies are
more likely to be acknowledged as the funding source in published work than before the out-
break. In particular, during the COVID-19 period, the most commonly acknowledged funders
are National Natural Science Foundation of China (NSFC) and the Ministry of Science and
Technology, China (MOST), which includes the Ministry of Science and Technology (MOST),
National Key Research and Development Program of China, National Basic Research Program
of China, National High Technology Research and Development Program of China.
Fig 1. Top 10 institutions in terms of publication quantity in coronavirus research in the COVID-19 period.
https://doi.org/10.1371/journal.pone.0236307.g001
Table 4. Funder of COVID-19 vs pre-COVID-19 research.
Funders Pre-COVID-19 COVID-19
Rank� % of funded
articles
Rank % of funded
articles
National Institutes of Health (NIH) 1 16.9% 3 12.2%
National Natural Science Foundation of China (NSFC) 2 14.3% 1 28.3%
Ministry of Science and Technology, China (MOST) 3 10.7% 2 12.9%
European Union (EU) 4 3.3% N/A N/A
National Research Foundation of Korea (NRFK) 5 3.1% N/A N/A
Fundamental Research Funds for the Central Universities (FRFCU) N/A N/A 4 3.7%
Japan Society for the Promotion of Science (JSPS) / Ministry of Education, Culture, Sports, Science and
Technology (MEXT)
N/A N/A 5 3.3%
Chinese Academy of Sciences (CAS) N/A N/A 5 3.3%
� “N/A” indicates the funder is not in the top 5 list.
https://doi.org/10.1371/journal.pone.0236307.t004
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In contrast, in the early days of the COVID-19 pandemic, United States funders are less
likely to be cited as the funding agency than before the pandemic. As an example, the United
States Department of Health, which includes the National Institutes of Health and its affiliated
funding agencies, drops from the most commonly acknowledged funder in coronavirus
research before COVID-19 to the third most commonly cited funder during the COVID-19
period.
Table 5 aggregates data on acknowledged funding sources by country-of-origin. During
COVID-19 we see Chinese agencies acknowledged as funding the majority of published
papers. In this period, at least 46% of articles acknowledge funding from Chinese agencies,
while only 18% of publications acknowledge funding from United States based funders. How-
ever, prior to the COVID-19 period, Chinese and United States agencies fund about the same
number of articles, and this will likely recalibrate as the United States recovers from the initial
lockdown. The shift could be due in part to the greater share of Chinese articles during
COVID-19, China’s longer experience with COVID-19, and support from the Chinese govern-
ment for coronavirus related research during the COVID-19 pandemic.
Structure of teams
Our primary research questions are related to the structure of teams and international collabo-
ration following the COVID-19 pandemic. Table 6 reveals the first results pertaining to these
research questions. The table shows that during the COVID-19 period, research teams are
smaller on average in published articles, although not in preprints. We note that preprint
teams are slightly larger, which could be due to the recency of these works, since larger teams
Table 5. Country origins of funder of COVID-19 vs pre-COVID-19 research.
Nationality Pre-COVID-19 COVID-19
Rank� % of funded articles Rank� % of funded articles
China Mainland 1 27.0% 1 46.0%
United States 2 25.8% 2 18.5%
South Korea 3 6.7% N/A N/A
United Kingdom 4 4.8% 5 3.9%
Europe 5 4.4% 3 4.4%
Japan N/A N/A 4 4.1%
� “N/A” indicates the country is not in the top 5 list.
https://doi.org/10.1371/journal.pone.0236307.t005
Table 6. Structure of scientific teams in COVID-19 vs pre-COVID-19 research.
Pre-COVID-19 COVID-19 COVID-19 (minus preprints)
Mean Median Std Dev N Mean Median Std Dev N Mean Median Std Dev N
Number of authors 7.09��� 6 5.57 6,105 7.83��� 6 8.58 4,327 6.38 5 7.61 2,472
Number of countries 1.76�� 1 1.34 6,106 1.52 1 1.32 4,327 1.65 1 1.32 2,472
International team dummy 0.42��� 0 0.49 6,106 0.31 0 0.46 4,327 0.35 0 0.48 2,472
International team dummy (excluding Chinese articles) 0.44��� 0 0.50 4,764 0.32 0 0.46 2,656 0.38 0 0.49 1,431
International team dummy (Chinese articles) 0.35�� 0 0.48 1,341 0.30 0 0.46 1,671 0.31 0 0.46 1,041
International team dummy (United States articles) 0.53��� 1 0.50 2,122 0.44 0 0.50 1,202 0.54 0 0.50 605
�, ��, ��� denote statistical significance at p values of 0.1, 0.05 and 0.01 in a difference of means test comparing pre-COVID-19 and COVID-19 outcomes. Comparisons
are between pre-COVID-19 outcomes and COVID-19 era outcomes.
https://doi.org/10.1371/journal.pone.0236307.t006
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take longer to produce output. The table also shows that articles in the COVID-19 period are
less likely to be internationally coauthored than pre-COVID-19, which is expected given the
transaction costs involved in distance collaboration in the early days of the pandemic. The
number of countries involved in coauthored articles also drops in the COVID-19 period. This
decline in international collaborations is lower for Chinese authors than for the rest of the
world, although this difference is not statistically significant. United States-based authors do
not experience a change in international collaborations in published articles (minus preprints);
however in preprints, we see a decline for United States-based researchers at the international
level.
Journal impact of peer-reviewed research
One concern that may arise from this rapid explosion of articles and changing team structures
in coronavirus research during the global pandemic is a very broad range of quality than prior
to the crisis. A review of impact factors attached to journals carrying coronavirus publications
shows that these works are actually published in higher impact journals than was the case in
the pre-COVID-19 period. To test for impact, we weight each published article in the two data-
sets by the Elsevier Scopus Source Normalized Impact per Paper (SNIP) of the publication
journal, which is calculated as the journal’s citation count per paper divided by its citation
potential in its subject area. We assess whether articles in the COVID-19 period are, on aver-
age, published in higher impact journals than pre-COVID-19 articles, and whether the growth
in Chinese authored publications is driven by publication in lower impact journals. Results are
shown in Table 7.
The positive coefficient on COVID-19 in Table 7 column 1 reveals that articles in our sam-
ple are published in journals with higher SNIP values in the COVID-19 period compared to
the pre-COVID-19 period. This suggests that journal editors and peer reviewers acted quickly
in response to the need for scientific understanding about the novel coronavirus. Chinese-
authored publications are appearing in as high impact journals as the rest of the world in both
the pre- and COVID-19 periods (column 2), and publications with international teams appear
in significantly higher impact journals than those with domestic-only teams (column 3). Col-
umn 4 reveals that Chinese authors publish in higher-impact journals during the COVID-19
era than the rest of the world although the difference is not statistically significant.
Table 7. Regression analysis of the relationship between team structure and the impact factor of journals publishing coronavirus research in pre- and during
COVID-19.
Independent variables Dependent variable—Source Normalized Impact per Paper
(1) (2) (3) (4) (5)
COVID-19 0.086��� (0.020) p = .000 0.088��� (0.019) p = .000 0.088��� (0.019) p = .000 0.064��� (0.024) p = .007 0.107��� (0.027) p = .000
Authors China -0.009 (0.013) p = .459 0.0012 (0.013) p = .921 -0.023�� (0.012) p = .044
International Team 0.069��� (0.012) p = .000 0.078��� (0.011) p = .000
COVID-19 x Authors China 0.062 (0.041) p = .127
COVID-19 x International Team -0.046 (0.039) p = .235
N 4,502 4,502 4,502 4,502 4,502
Estimates stem from ordinary least square model regression specifications with dependent variables being inverse hyperbolic sine transformed SNIP of a publication in
the sample, and independent variables being the period of the publication (COVID-19 or pre-COVID-19) (column 1), whether the authors of the publication are from a
Chinese institution (column 2), and whether the publication author team is international (column 3). In columns 4, 5, and 6 we include interaction terms of COVID-19
period and the team structure to assess whether there is a different relationship between team structure and SNIP of a publication pre and during-COVID-19.
Robust standard errors in parentheses.
�, ��, ��� denote statistical significance at p values of 0.1, 0.05 and 0.01.
https://doi.org/10.1371/journal.pone.0236307.t007
PLOS ONE COVID-19 international collaboration
PLOS ONE | https://doi.org/10.1371/journal.pone.0236307 July 21, 2020 8 / 15
Table 7, column 5 shows that although internationally coauthored articles are published in
higher impact journals than domestically teamed ones, there is no differential increase in the
COVID-19 era for international versus domestic teams. Together with the documented decline
in international collaborations, this result suggests that domestic teams during COVID-19 are
increasing the impact factor of the journals they publish in as compared to before.
International networks of collaboration
Network collaborative patterns have shifted in the COVID-19 era, as expected. Table 8 shows
network metrics for major actors in the global network in pre-COVID-19 and COVID-19.
The United States is the core player in both the pre-COVID-19 and COVID-19 networks.
However, with a decreasing measure of collaboration linkages, or degree, during the COVID-
19 era, the United States shows a decreasing role in the network. This is particularly true in
comparison to China and Italy, which show increased collaboration linkages during the
COVID-19 period, as measured by degree. Among the nations listed, China, the United King-
dom, and Italy show an increase in their normalized betweenness centrality during the
COVID-19 pandemic, as compared to the 24-months leading up to the pandemic, indicating
an increase in their bridging roles in the network. In terms of eigenvector centrality, the top
four nations—United States, China, the United Kingdom, and Italy—retain their centrality
into the COVID-19 period but Germany drops considerably in the early days of COVID-19,
perhaps due to a lag in research output.
Figs 2 and 3 reveal the network structures in coronavirus research among nations in pre-
COVID-19 and COVID-19 periods. Fig 2 illustrates that the United States is at the core of the
international collaborative network in coronavirus research before the COVID-19 pandemic,
while China is the third most central country in the network. Given the dominance of the
United States in terms of research output in the pre-COVID-19 period, this is not a surprise,
as the networks are not normalized by size. The figure also shows that connections between
the United States and China before the crisis constitute the strongest bilateral link in the field,
while there are also strong connections between the United States and the United Kingdom,
France, Germany, Saudi Arabia, India, and Canada.
Fig 3 presents the network of international collaboration in the COVID-19 period. As
expected, given the shorter period available for production of research, the network is sparse
compared to the pre-COVID-19 period. However, we can see that the United States-China
relationship has intensified compared to the pre-COVID-19 period. Moreover, these two
nations maintain their status as the most centralized players in the collaborative network. Sci-
entifically advanced nations like the United Kingdom, Germany, France, Italy, and Canada
remain active in the network, although their strongest connections are still with the United
States. Germany’s role in the network declines considerably, as do many other nations.
Table 8. Network metrics for selected nations in COVID-19 and pre-COVID-19.













United States 97 1,915 0.163 1 74 907 0.204 1
China 62 687 0.023 0.802 52 698 0.063 0.840
United
Kingdom
82 992 0.064 0.954 66 523 0.129 0.952
Italy 61 364 0.015 0.805 49 271 0.059 0.806
Germany 78 639 0.050 0.930 55 261 0.067 0.873
https://doi.org/10.1371/journal.pone.0236307.t008
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Fig 4A and 4B present the egonets with China as the central player to illustrate China’s
collaborative pattern in the pre- and COVID-19 periods. The figures further support the
observation that China’s strongest collaborative link is with the United States and that this
relationship intensifies in the COVID-19 period. Overall, the share of all coronavirus publica-
tions that comprise China-United States collaborations increases to 4.9% from 3.6% in the
Fig 2. Network of international collaborative relationships in pre-COVID-19 period, January 1, 2018 to
December 31, 2019. Edges lower than 4 are removed.
https://doi.org/10.1371/journal.pone.0236307.g002
Fig 3. Network of international collaborative relationships during COVID-19 period, January 1, 2020 to April 8,
2020. Edges lower than 2 are removed.
https://doi.org/10.1371/journal.pone.0236307.g003
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COVID-19 period. Table 9 columns 1 and 2 confirms the increase in the rate of China—
United States collaborations as statistically significant in the COVID-19 period in all coronavi-
rus articles and all internationally collaborative coronavirus articles.
That said, because of China’s increased quantity of publications in the COVID-19 period,
the relative share of collaboration with the United States as a function of overall Chinese publi-
cations drops, as shown in Table 9 columns 3 and 4. In an absolute sense, China is producing
more and higher quality work on its own. In addition to increasing their domestic outputs,
China also strengthened links with Canada, Japan, the Netherlands, Italy, and India in an effort
to advance COVID-19 research worldwide.
Similarly, Fig 5A and 5B show the egonet diagram of the United States as the central player,
and further support the observation that during COVID-19, the United States has solidified its
relationships with a handful of specific countries, particularly China. The consolidation of the
United States—China relationship is closely related to dominant role of China in articles pub-
lished during the COVID-19 pandemic. The United States’ collaboration with China remains
its strongest link; this can also be seen in Table 9 columns 5 and 6. In contrast, the United
States’ relative share of collaborative articles with many other nations, such as the United
Fig 4. Ego-networks of China in pre-COVID-19 and COVID-19 periods.
https://doi.org/10.1371/journal.pone.0236307.g004
Table 9. Regression analysis of the rate of pairwise collaboration between China and the United States in COVID-19 and pre-COVID-19 research.
Independent
variable
Dependent variable—China-United States Collaboration















United States authored articles
with international collaborations
p-value .001 .000 .000 .131 .000 .000
N 10,432 3,915 3,012 976 3,324 1,662
Estimates stem from linear probability models specifications with dependent variables being dummy variables taking the value of 1 if the article contains a China-United
States collaboration and independent variable being COVID-19 period or pre-COVID-19. All models include controls for type of article (formal/informal). The samples
for the regression in model 1 is the full sample of articles, model 2 is just the set of internationally collaborative articles, model 3 is just Chinese authored articles, 4 is just
Chinese articles authored with international collaborators, model 5 if just United States authored articles and model 6 is just United States authored articles with
international collaborators.
Robust standard errors in parentheses.
�, ��, ��� denote statistical significance at p values of 0.1, 0.05 and 0.01.
https://doi.org/10.1371/journal.pone.0236307.t009
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Kingdom, India, Canada, Germany, France, and Australia, and developing countries declines
considerable during COVID-19.
Research topics in coronavirus articles
Research topics identified from coronavirus articles in pre-COVID-19 and COVID-19 periods
provide clues to the potential changes of research emphases during the crisis. Fig 6A reveals
Fig 5. Ego-networks of the United States in COVID-19 and pre-COVID-19 periods.
https://doi.org/10.1371/journal.pone.0236307.g005
Fig 6. Co-term networks of the COVID-19 research in pre- and COVID-19 periods.
https://doi.org/10.1371/journal.pone.0236307.g006
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five main clusters of research topics that appear in coronavirus articles in the pre-COVID-19
period, including viral replication (red nodes), viral infection (green nodes), respiratory infec-
tions (blue nodes), public health topics (yellow nodes and epidemiology-related blue nodes),
and molecular epidemiology (purple nodes). We interpret the relatively clear boundaries
between these clusters as evidence for the existence of established research area with well-
defined concepts and explicit topics. Comparably, Fig 6B illustrates the focus on a more
diverse, and ‘chaotic’ set of research topics during the early COVID-19 period. The largest
node representing a research topic is “Wuhan”, reflecting the location of the first occurrence
of the virus. The network reveals a diverse range of topic pursued by researchers during
COVID-19 including epidemiological characteristics, symptom descriptions, geographical fea-
tures, and public health concerns (blue and orange nodes). This indicates the predominant
concerns amongst researchers, but also reveals that researchers lack a clear focus and coordi-
nation. We expect this to change as the features of the virus, the public health concerns, and
patient care practices become clearer.
Discussion
Science is increasingly a team activity [15], with scientists self-organizing into collaborations,
including international collaborations, as needed by the research questions [6,16]. In particu-
lar, the involvement of many more countries coming into the global network of scientists over
the past 20 years has led to dramatic shifts in the structure of scientific activity around the
world [7]. On the one hand, international collaboration can allow scientists to access expertise,
funding, and resources outside of their own nation. However, the search and coordination
costs of this type of collaboration are high. For scientists, the decision to engage in interna-
tional collaboration represents this inherent trade-off.
During a global pandemic these trade-offs intensify. The need for broad expertise and
pooled resources is greater than ever, but, an urgent need for scientific input into public health
and economic decisions puts a premium on transaction costs associated with long-distance
and cross-cultural communications. Based on this logic, in this study we hypothesize that a
global pandemic would result in a reduction in the usual search and outreach, since scientists
need to limit the coordination costs of research. Specifically, we expect to see that researchers
return to known-collaborators and smaller teams to speed the research process during a global
pandemic. We test these hypotheses through comparing the patterns found in coronavirus
related research prior to and during the COVID-19 global pandemic and find that the pan-
demic is inducing changes in the global organization of science, at least as related to
coronavirus.
A review of early publication and cooperation patterns of scientific publications at the
global level highlights that scientists rapidly reorganized to address the crisis posed by
COVID-19 along the lines of greater efficiency and narrower focus. As expected, the dynamics
of collaboration and teaming appear to shift to rely on fewer team members, which reduces
the transaction costs of communicating among the group, and can, in theory, speed the
research and writing processes. The challenge of the novel virus strengthens the research rela-
tionship between China and other scientifically advanced countries, especially with the United
States. At the same time, Chinese researchers become more independent increasing the vol-
ume, and quality, of domestic output in the COVID-19 era. Moreover, the Chinese research
funding agencies played a vital role in the earliest days in supporting high quality research and
development work in China. These findings are in contrast to some popular accounts that Chi-
nese scientists are withholding valuable information and reducing cooperation in the early
stages of the global pandemic [17].
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Although we interpret the findings as providing insight into the theoretical expectations,
this study has three main limitations. First, the period used for analysis pre-COVID-19 and
during COVID-19 is different. Due to the nature of data collection, we had a much shorter
period available to us for the COVID-19 period. We account for this in the statistical analysis,
however we anticipate that some of our trends may change longer term. In particular, the geo-
graphic nature of scientific production and funding may represent the geographic spread of
the coronavirus. For example, the virus spread through China before it was observed in the
United States, and so it is not a surprise that the Chinese government and funding agencies
allocated resources earlier than the United States. Future research should explore longer term
dynamics in scientific funding and productivity around the world.
Second, we use the Source Normalized Impact per Paper (SNIP) to reflect the impact of
research. There are many possible measures of research impact, including raw citations, nor-
malized citation scores, and practical measures such as policy influence, news take-up and dis-
cussions in online forums. Despite the limitations with the use of SNIP to assess impact,
including the influence of publication language, open access journals, fast track publications
and the fact that publications from zero impact journals are excluded [18], we chose this mea-
sure due to the real time data collection precluding the use of citation measures and alternative
measures of influence. Future research should use a variety of impact measures to identify the
most important and impactful research during the COVID-19 period.
Finally, our study is limited by the data available on scientific production and funding. In
particular, our measure of funding source for coronavirus research is limited. We exploit the
text in funding acknowledgments in articles, many of which do not have funding acknowledg-
ments as it is not a requirement by the journal or database. Future work could use data directly
from funders themselves as it becomes available or surveys of researchers to ascertain any
trends.
That said, we interpret the findings from this study as providing insight into the theoretical
framework, and this paper suggests that global scientists face a trade-off in decisions on inter-
national collaborative activities around time and efficiency, and that the trade-off changes dra-
matically during a time of urgency, such as the COVID-19 pandemic. The observed reduction
in the rate of international collaborations and consolidation of the strongest existing bilateral
relationships during the COVID-19 pandemic could have consequences for the organization
of science and direction of research. One of the most important of these findings is a reduction
in participation of researchers from developing countries in coronavirus related research.
Future work will examine the nature of teaming, preferential attachment, the role of influential
individuals in the global networks as well as the consequences of the organization of science
on the evolution of research topics during the COVID-19 pandemic.
Policymakers who are tracking and guiding research into coronavirus topics and vaccines
may wish to be aware of the changing dynamics of international teams. While it is important
to increase efficiency, smaller teams could mean that knowledge diffusion and wide-ranging
expertise and novelty are reduced [3,15]. This fact is particularly true for those research institu-
tions which are not among the most elite institutions or within those teams gathered around
leading scientists who have ample funding. The results of the narrowing and focusing of
research may mean that results arrive more quickly, but it also means the results and capacities
are diffused more slowly. Validation may be compromised. Policy actions to address these
inequities may be needed in the very near term.
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